Join KHI

Publications

Barrier Type

All Clinical Trial Endpoints Clinical Trial Infrastructure Data Standards Education and Resources Patient Preferences Toolkits Annual Report Strategic Plan

Portfolio

All Devices Drugs Biologics Patient and Family Engagement
Submit a Project

Understanding Clinical Research: A Guide for Parents and Caregivers

  • Drugs, Education and Resources, Patient and Family Engagement

Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy

  • Clinical Trial Endpoints, Drugs

Pediatric Clinical Trials Clearing House Pilot Program

  • Drugs

Roadmap For Advancing Awareness, Genetic Testing, And Clinical Studies Of Apol1 Kidney Disease

  • Drugs, Education and Resources

Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes

  • Drugs, Patient Preferences

Kidney Transplant Therapeutic Area User Guide v1.0

  • Data Standards, Drugs

CDISC Therapeutic Area User Guide for Diabetic Kidney Disease

  • Data Standards, Drugs

Overcoming Barriers to Drug Development in Children with CKD : Clinical Journal of the American Society of Nephrology

  • Clinical Trial Endpoints, Drugs

Developing Therapies for C3 Glomerulopathy Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group

  • Clinical Trial Endpoints, Drugs

End Point Considerations for Clinical Trials in Enteric Hyperoxaluria

  • Clinical Trial Endpoints, Drugs

End Points for Clinical Trials in Primary Hyperoxaluria

  • Clinical Trial Endpoints, Drugs

Primary Hyperoxaluria The Patient and Caregiver Perspective

  • Clinical Trial Endpoints, Drugs
Load More